IGC Pharma share price logo

IGC Pharma

AMEX: IGC

$0.27

+0.00

(+1.81%)

as on

IGC Pharma Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.27
    $0.28
    downward going graph

    1.78%

    Downside

    1.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.24
    $0.45
    downward going graph

    14.51%

    Downside

    63.99%

    Upside

    downward going graph

IGC Pharma share price movements today

Previous Close
$0.27
Open
$0.28
Volume
936.9K
Market Cap
$27.9M
Day's Low - High
$0.27 - $0.28
52 Week Low - High
$0.24 - $0.45

IGC Pharma Historical Returns

1 Month Return
-7.91 %
3 Month Return
-2.14 %
1 Year Return
-32.24 %
3 Year Return
-21.19 %
5 Year Return
-81.3 %

IGC Pharma Stock Fundamentals & Key Indicators

Check IGC Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$27.9M

EPS (TTM)

-0.0823

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.33

Industry PE ratio

-3.02

PEG Ratio

0.34

EBITDA

-7.4M

Revenue (TTM)

1.1M

Profit Margin

21.91%

Return On Equity TTM

-113.58%

IGC Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of IGC Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
IGC Pharma image
IGC Pharma
Buy$27.9M-81.30%-3.3321.91%0.00%
Revolution Medicines image
Revolution Medicines
StrongBuy$44.1B609.62%-23.340.00%0.00%
Moderna image
Moderna
Neutral$75.4B-44.29%-24.08-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.5B180.98%30.1986.04%0.00%
Regeneron image
Regeneron
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for IGC Pharma Stock including INR - Dollar returns

The IGC Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

IGC Pharma investment value today

Current value as on today

₹73,548

Returns

-₹26,452

(-26.45%)

Returns from IGC Pharma Stock

-₹32,241 (-32.24%)

Dollar Impact

₹5,788 (+5.79%)

Analyst Recommendation on IGC Pharma Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for IGC Pharma. Average target price of $6

IGC Pharma Share Price Target

Get share price movements and forecasts by analysts on IGC Pharma.

What analysts predicted

95.42%UPSIDE

Target Price

$6

Current Price

$0.2749

Analyzed by

5 Analysts

Target

$6.00

IGC Pharma target price $6, a slight upside of 95.42% compared to current price of $0.2749. According to 5 analysts rating.

Indian Investors' Interest in IGC Pharma Stock

Search interest for IGC Pharma Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:32% versus previous 30 day period

IGC Pharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-2
-1
-1
-1
-1
-2
-2
-2
-2
EBITDA
-2
-2
-1
-1
-1
-1
-1
0
-2
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-1
-1
-1
-1
-1
0
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-2
-1
-1
-1
-1
-1
0
-2
-2
Net Profit Margin
8.47%
59.93%
48.06%
40.47%
46.67%
46.95%
51.83%
12.57%
17.35%
18.11%

IGC Pharma Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Jun 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
0
2
5
4
0
0
0
1
1
1
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-1
-4
-6
-8
-15
-11
-9
-7
-10
EBITDA
-1
-1
-4
-6
-8
-14
-10
-12
-6
-6
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
-4
-7
-8
-15
-11
-13
-7
-6
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-1
-1
-4
-7
-8
-15
-11
-13
-7
-6
Net Profit Margin
37.60%
3.72%
2.58%
2.82%
-38.86%
48.87%
-17.34%
54.50%
48.70%
29.68%

IGC Pharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-2
-1
-1
-1
-1
-1
0
-2
-2
Operating Cash Flow
0
-1
0
-1
0
-1
-2
-1
-1
-1
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
2
0
0
0
0
3
1
0
1
Change in Cash
0
0
0
-1
0
0
0
0
0
0

IGC Pharma Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Jun 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
-1
-1
-4
-7
-8
-15
-11
-13
-7
-6
Operating Cash Flow
-1
-1
-3
-8
-10
-7
-7
-5
-4
-5
Investing Cash Flow
0
0
0
-9
3
0
0
0
0
0
Financing Cash Flow
0
3
27
0
14
4
0
3
4
5
Change in Cash
0
1
23
-18
7
-4
-7
-1
0
0

Global Institutional Holdings in IGC Pharma

Check out the Institutions with significant holdings in IGC Pharma.

Funds
Holdings
AdvisorShares
0.91%
Vanguard
0.79%
VANGUARD INDEX FUNDS
0.69%
Fidelity Concord Street Trust
0.63%
Ken Fisher
0.04%

IGC Pharma News & Key Events

    Insights on IGC Pharma

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 599.1%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.2% return, outperforming this stock by 103.3%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 3 quarters, 350.0K → 265.0K (in $), with an average decrease of 12.9% per quarter

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 3 quarters, -726.0K → -2.93M (in $), with an average decrease of 126.5% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 1 year, IGC stock has moved down by -32.2%

    About IGC Pharma

    IGC Pharma, Inc. operates as a pharmaceutical firm, currently in the clinical development phase, dedicated to pioneering novel treatments for Alzheimer's, a debilitating condition. The company's pipeline includes two experimental drug candidates aimed at this disease: IGC-AD1, which is presently undergoing a Phase 2 clinical study for addressing agitation associated with Alzheimer's-related dementia, and TGR-63, which is still in its preclinical stage. Beyond its therapeutic development efforts, IGC Pharma also explores the application of artificial intelligence (AI) to advance Alzheimer's research. Established on April 29, 2005, by Ram Mukunda, the company maintains its principal office in Potomac, Maryland.
    OrganisationIGC Pharma
    Headquarters10224 Falls Road, Potomac, MD, 20854, US
    IndustryBiotechnology
    CEORam Mukunda

    Key Management of IGC Pharma

    Name

    Title

    Mr. Rohit Goel CPA, M.B.A.

    Director of Accounting & Senior Director

    Susana Salgar

    Sales Manager

    Mr. Ram Mukunda

    Founder, President, CEO & Director

    Ms. Claudia Grimaldi

    VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director

    Benysh Qureshi Esq., M.B.A.

    Director of Operations

    FAQs

    What is IGC Pharma share price today?

    IGC Pharma share price today is $0.27 as on at the close of the market. IGC Pharma share today touched a day high of $0.28 and a low of $0.27.

    What is the 52 week high and 52 week low for IGC Pharma share?

    IGC Pharma share touched a 52 week high of $0.45 on and a 52 week low of $0.24 on . IGC Pharma stock price today i.e. is closed at $0.27,which is 39.02% down from its 52 week high and 16.98% up from its 52 week low.

    What is IGC Pharma's market capitalisation today?

    IGC Pharma market capitalisation is $0.00T as on .

    How to invest in IGC Pharma Stock (IGC) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for IGC Pharma on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy IGC Pharma Stock (IGC) from India?

    Indian investors can start investing in IGC Pharma (IGC) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹963.00 in IGC Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on IGC Pharma share’s latest price of $0.27 as on October 3, 2026 at 8:45 am IST, you will get 36.3769 shares of IGC Pharma. Learn more about fractional shares .

    What are the returns that IGC Pharma has given to Indian investors in the last 5 years?

    IGC Pharma stock has given -81.3% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?